Home/Filings/4/0001127602-17-020967
4//SEC Filing

HAEMONETICS CORP 4

Accession 0001127602-17-020967

$HAECIK 0000313143operating

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 5:50 PM ET

Size

6.8 KB

Accession

0001127602-17-020967

Insider Transaction Report

Form 4
Period: 2017-06-06
Ryding Neil 122-62-507
EVP, Global Manufacturing
Transactions
  • Award

    Common Stock

    2017-06-06$41.64/sh+2,401$99,97819,676 total
  • Award

    Non-qualified Stock Option (Right to Buy)

    2017-06-06$41.64/sh+9,836$409,5719,836 total
    Exercise: $41.64From: 2018-06-06Exp: 2024-06-06Common Stock (9,836 underlying)
Footnotes (2)
  • [F1]Restricted Stock Unit Grant which vest 25% per year over 4 years following the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan.
  • [F2]Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.

Issuer

HAEMONETICS CORP

CIK 0000313143

Entity typeoperating
IncorporatedMA

Related Parties

1
  • filerCIK 0000313143

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 5:50 PM ET
Size
6.8 KB